Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Amphastar Pharmaceuticals Drug Stock Nears All-Time High After 74% Earnings Growth
04:53pm, Thursday, 20'th Apr 2023
This drug stock gained 35% since its earnings report. The biotech got FDA approval for its opioid overdose nasal spray.
Strength Seen in Amphastar (AMPH): Can Its 6.4% Jump Turn into More Strength?
01:42pm, Friday, 14'th Apr 2023
Amphastar (AMPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
04:10pm, Wednesday, 12'th Apr 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 12, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Jacob Liawatidewi, EVP of Corporate Administration, Tony Marrs
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Amphastar Pharmaceuticals (AMPH)'s Technical Outlook is Bright After Key Golden Cross
11:29am, Monday, 13'th Mar 2023
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
2 Stocks to Buy Now After Powell Flips the Narrative
07:02pm, Thursday, 09'th Mar 2023
Expectations for the next FOMC meeting have seen odds of a 50bps rate hike go from extremely unlikely to highly likely
Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year?
11:17am, Wednesday, 08'th Mar 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Annovis Bio, Inc. (ANVS) have performed compared to their sector so far this year.
3 Generic Drug Stocks to Watch Amid Macro Headwinds
12:03pm, Friday, 03'rd Mar 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
Why Shares of Amphastar Pharmaceuticals Rose Today
01:54pm, Wednesday, 01'st Mar 2023
The company reported a record revenue year and increased EPS.
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates
09:50pm, Tuesday, 28'th Feb 2023
Amphastar (AMPH) delivered earnings and revenue surprises of 92.11% and 6.80%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2022 Earnings Call Transcript
09:15pm, Tuesday, 28'th Feb 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET Company Participants Bill Peters - Chief Financial Officer, Treasurer, Executive Vice Presi
Amphastar: Generating High Incremental Growth From Tidy Earnings Reinvestment
02:29am, Thursday, 09'th Feb 2023
Amphastar stock has generated high rates of post-tax earnings growth with small increments of additional capital investment since FY20. The incremental returns on capital are above historical returns
3 Generic Drug Stocks to Watch Amid Inflation Pressures
12:02pm, Wednesday, 07'th Dec 2022
The impact of inflationary headwinds and pricing pressure on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and SLGL.
Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference
06:00am, Tuesday, 22'nd Nov 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 22, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, Sr. Vice President Regulatory Affairs and Cl
Amphastar: Growth Remains Intact
07:45am, Monday, 14'th Nov 2022
Quarter-over-Quarter growth in revenue has persisted due to the consistent launch of new product pipelines. The overall financial position is substantially strong, which offers significant flexibility
